Vaccination Shows No Benefit for Primary Melanomas

The use of GM2-KLH/QS-21 vaccination in stage II melanoma patients did not improve outcomes, according to the results of the EORTC 18961 phase III trial.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news